
Mouse OPN PicoKine ELISA Kit standard curve
Mouse OPN / Osteopontin ELISA Kit PicoKine(r)
EK0483
Product group Assays
Overview
- SupplierBoster Bio
- Product NameMouse OPN PicoKine ELISA Kit
- Delivery Days Customer9
- ApplicationsELISA
- Applications SupplierELI
- Assay Detection Range156 pg/ml - 10,000 pg/ml
- Assay Sensitivity<10 pg/ml
- Assay Time25-30
- CertificationResearch Use Only
- Scientific DescriptionMouse OPN / Osteopontin ELISA Kit PicoKine® (96 Tests). Quantitate Mouse Spp1 in cell culture supernatants, serum, plasma (heparin, EDTA) and urine. Sensitivity: 10pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each Picokine kit delivers precise quantification, high sensitivity, and excellent reproducibility. Only our most reliable and effective kits qualify as Picokine, guaranteeing top-tier results for your assays.
- Reactivity SupplierMouse OPN
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC41116158
References
- Ma M, Fan AY, Liu Z, et al. Baohuoside I Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss. Front Pharmacol. 2022,13:874952. doi: 10.3389/fphar.2022.874952Read this paper
- Yin HM, Liu W, Huang YF, et al. Surface Epitaxial Crystallization-Directed Nanotopography for Accelerating Preosteoblast Proliferation and Osteogenic Differentiation. ACS Appl Mater Interfaces. 2019,11(46):42956-42963. doi: 10.1021/acsami.9b14800Read this paper
- Zhao B, Xu H, Gao Y, et al. Promoting osteoblast proliferation on polymer bone substitutes with bone-like structure by combining hydroxyapatite and bioactive glass. Mater Sci Eng C Mater Biol Appl. 2019,96:1-9. doi: 10.1016/j.msec.2018.11.006Read this paper
- Xu MX, Qin YT, Ge CX, et al. Activated iRhom2 drives prolonged PM(2.5) exposure-triggered renal injury in Nrf2-defective mice. Nanotoxicology. 2018,12(9):1045-1067. doi: 10.1080/17435390.2018.1513093Read this paper
- Qin X, Yan M, Wang X, et al. Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway. Theranostics. 2018,8(4):921-940. doi: 10.7150/thno.22182Read this paper

